Two recent studies suggest that brain changes in chronic pain are not all pathological
Chronic pain, and the biological mechanisms contributing to pain, are as multifarious and complex as the people who experience them. Because a better understanding of individual differences offers opportunities to design better targeted treatments, neurological markers that reflect brain contributions to chronic pain, disability and related symptoms such as disturbances of body perception are sought. Indeed, the Holy Grail of “precision medicine” for chronic pain requires the discovery of biomarkers that are specific and sensitive to pathological mechanisms. When researchers investigate brain changes in individuals with chronic pain, however, these changes are normally assumed to be pathological. In contrast to this, I have been involved with two recent brain imaging studies that point to possible adaptive changes in people with chronic pain.
The most recent of these studies investigated Event-Related Potentials (ERPs) in individuals with Complex Regional Pain Syndrome (CRPS) (currently available online with the Journal of Pain ). The study builds on work showing that patients with CRPS commonly (but not universally) show signs of difficulty discriminating touch sensations – for example when given the task of identifying which digit on the hand was touched by the experimenter when the patient is not able to see their hand to help make the judgement (reviewed in ). We investigated tactile processing in 13 people with CRPS, focussing on a robust late-latency event-related potential (ERP) component – the P300 – as one potential biomarker of cognitive mechanisms contributing to difficulty in discriminating touch. As well as measuring their ability to discriminate which digit had been touched, we also measured the time taken to verbally report this back to the experimenter. Until now, there has been little attempt to differentiate mechanisms contributing to these two aspects of discrimination accuracy and response time.
We found that longer response times in those with CRPS (compared to a control group) were associated with a larger amplitude P300 response, a signal that we found originated from supplementary motor area (SMA). The SMA is a region involved both in making decisions about sensations (e.g. in our experiment, which digit was touched) and also planning motor responses (e.g. reporting which digit was touched back to the experimenter). This suggests that the SMA contributes to the slowed response times in people with CRPS. An unexpected finding, however, was that the P300 was greater in those people who reported being less disabled on their CRPS-affected limb. We therefore speculated that larger P300 responses might reflect a mechanism that compensates for CRPS-related disability, rather than being a source of pathology per se. Our finding requires replication and a more detailed investigation to understand the relation of cortical activity to limb functioning. But it points to an often unacknowledged possibility in findings from brain imaging studies: that differences we observe in people with medical conditions might sometimes be markers of positive adaption rather than pathology.
An earlier discovery of a possible “resilience factor” was from a study that investigated the density of opioid receptors in the brain in people with arthritis using the technique of Positron Emission Tomography (PET). Previously, research using animal models of chronic pain had found that as the animal experiences more prolonged pain, the number of opioid receptors in the brain increases, which might serve to increase the capacity of the animal to cope with pain. In people with arthritis, we found that people with a greater number of opioid receptors were found to have a greater pain threshold. Importantly, those who had experienced a greater intensity of chronic pain in the 7 days prior to undergoing the PET scan had a greater density of opioid receptors in the brain, consistent with the previous findings in animals. Taken together these findings suggest a possible adaptive rather than a pathological change, this time in brain neurochemistry, as a result of chronic pain.
Both studies challenge the archetypal view of the ‘patient’, which is that if they present to their doctor with symptoms, there can only be something wrong with them. Rarely do researchers consider what might be right with the person. This is particularly important to consider in the brain sciences: the brain is a complex organ providing the biological capacity underlying all cognition and behaviour. We also know that people can learn new beneficial ways of thinking and acting as a result of enormous challenges in their life circumstances, which they may not otherwise have had the impetus to learn. It therefore seems highly unlikely that persistent differences in brain structure and function in people in chronic pain are entirely pathological. So let’s not be overly negative when interpreting findings from clinical studies using brain imaging.
About Christopher Brown
Christopher Brown, Ph.D. is Lecturer in the Department of Psychological Sciences at the University of Liverpool, UK. He is also a visiting researcher at the University of Manchester and University of Cambridge. His main research is on brain neuroplasticity in chronic pain.
- Kuttikat, A. et al. Altered Neurocognitive Processing of Tactile Stimuli in Patients with Complex Regional Pain Syndrome (CRPS). J. Pain (2017). doi:10.1016/j.jpain.2017.11.008
- Kuttikat, A. et al. Neurocognitive and Neuroplastic Mechanisms of Novel Clinical Signs in CRPS. Front. Hum. Neurosci. 10, 16 (2016).
- Brown, C. A. et al. Striatal opioid receptor availability is related to acute and chronic pain perception in arthritis: does opioid adaptation increase resilience to chronic pain? Pain 156, 2267–75 (2015).